Home › Multiple Myeloma › New York › Staten Island
Multiple Myeloma clinical trials in Staten Island, NY
13 studies for Multiple Myeloma are looking for participants at sites in and around Staten Island (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RecruitingPhase 1/2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- MSK Monmouth, Middletown · 12 mi away
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering Monmouth (Consent only), Middletown · 12 mi away
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi away
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recruiting
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi away
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RecruitingPhase 3
- MSK Monmouth, Middletown · 12 mi away
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi away
A Dietary Study for People With Multiple Myeloma
Recruiting
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in Staten Island
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer20 studies
- Prostate Cancer17 studies
- Acute Myeloid Leukemia13 studies
- Lung Cancer13 studies
- Bladder Cancer12 studies
- Endometrial Cancer11 studies
- Cancer (all types)10 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- Colorectal Cancer9 studies
- Pancreatic Cancer9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.